RSV Vaccine in Ontario: Cost for Seniors Budget Seniors, March 19, 2026March 19, 2026 💉🛡️ 🇨🇦 Ontario Ministry of Health • NACI • Verified Straight answers from official Ontario Ministry of Health sources: who gets it free, what it costs if you do not qualify, where to get it, and why the science strongly supports getting vaccinated. Ⓡ BudgetSeniors.com — Sources: ontario.ca, NACI, CCDR, Public Health Ontario • Verified March 2026 💡 10 Key Takeaways Before You Call Your Doctor Respiratory Syncytial Virus (RSV) is not just a children’s illness. In older adults, particularly those over 75 or with underlying health conditions, RSV can cause serious pneumonia, hospitalization, and death at rates comparable to influenza. Ontario now offers a free RSV vaccine to all residents aged 75 and older, and to many adults aged 60 to 74 who meet specific high-risk criteria — with the program expanded significantly for the 2025–2026 season. Here is what every Ontario senior needs to know. 1 If you are 75 or older in Ontario, the RSV vaccine is completely free. The Ontario Ministry of Health expanded the publicly funded adult RSV program in fall 2025 to include all residents aged 75 and older, regardless of where you live or whether you have other health conditions. No co-pay. No prescription fee. No charge of any kind for eligible residents who have not previously received a publicly funded RSV vaccine. 2 Adults aged 60 to 74 may also qualify for free vaccination — but only if you meet specific high-risk criteria. These include living in a long-term care home, Elder Care Lodge, retirement home, or similar setting; being in hospital receiving alternate level of care; or having certain immunocompromising conditions such as moderately to severely immunocompromised glomerulonephritis. If you are 60 to 74 and do not meet these criteria, you can purchase the vaccine privately. 3 The private purchase cost is approximately $250 per dose, according to Wellington-Dufferin-Guelph Public Health. You need a prescription from a family doctor or other primary care provider, then pay at a pharmacy. Some private insurance plans cover all or part of this cost. The Ontario Ministry of Health does not reimburse private vaccine purchases. 4 The free vaccine is NOT available through pharmacies for eligible seniors. This is one of the most important practical points to understand. If you qualify for the publicly funded program, you must get the vaccine through your family doctor, a nurse practitioner, a public health immunization clinic, or your long-term care facility. Walking into a pharmacy and requesting the free Ontario-funded vaccine is not how the program works. 5 You only need one dose — and if you already received a publicly funded RSV vaccine in a prior season, you do not need another one. Unlike the flu shot, the RSV vaccine is not an annual requirement. NACI does not currently recommend booster doses. Studies suggest multi-year protection, with ongoing research to determine exactly how long the protection lasts. One lifetime dose under the public program is what is currently recommended. 6 You can get the RSV vaccine on the same day as your flu shot and COVID-19 vaccine. Ontario health authorities specifically encourage co-administration to simplify fall vaccination appointments. Getting all three vaccines at the same visit is safe, convenient, and recommended. 7 The RSV season runs November through April, peaking in December. You should get vaccinated as early as possible in the fall — ideally September or October — to build immunity before the virus begins circulating in the community. Do not wait until December when the virus is already widespread. 8 The vaccines are highly effective. Arexvy (GSK) has demonstrated approximately 83% efficacy in preventing lower respiratory tract disease caused by RSV, and approximately 94% efficacy in preventing severe RSV illness, according to Health Canada’s review of clinical trial data. These are strong protection rates for a vaccine against a serious respiratory illness in older adults. 9 RSV is a serious disease in seniors — not a mild cold. Canadian hospitalization data published in the Canada Communicable Disease Report shows that 16% of adults hospitalized with RSV require ICU admission, and the in-hospital case fatality ratio ranges from 5% to 9%. A peer-reviewed study in the Journal of the American Geriatrics Society found RSV hospitalization is more severe than influenza hospitalization in older adults, with greater cardiovascular complications afterward. 10 NACI recommends that adults aged 50 to 74 without qualifying criteria consider the vaccine as an individual decision with their healthcare provider. Even if you do not qualify for the free program, the National Advisory Committee on Immunization’s guidance acknowledges that the vaccine may be worth considering for adults 50 and over who are at higher personal risk due to health conditions — it is just not currently funded for this group in Ontario. Sources: ontario.ca/page/respiratory-syncytial-virus-rsv-prevention-programs (Ministry of Health, Dec 2025); ottawa.ca/rsv-newsroom (Ottawa Public Health, fall 2025); CBC News Aug 27, 2025 (OHM Sylvia Jones announcement); lunghealth.ca (Lung Health Foundation Ontario expansion summary, Nov 2025); wdgpublichealth.ca (~$250 private cost); oma.org RSV immunization program (booster not recommended, no pharmacy funding); NACI CCDR summary Aug 2025 (CCDR 51:8); CCDR Jan 2025 burden study (ICU 16%, CFR 5–9%); Health Canada / FDA Arexvy efficacy data (83% LRTD, 94% severe) 💰 Who Pays Nothing and Who Pays ~$250 ✅ Free — All Residents $0 — Fully Covered Age 75 and older. Any Ontario resident aged 75+ who has not previously received a publicly funded RSV vaccine qualifies for full provincial coverage. No income test. No health condition required. New for fall 2025 season. All 75+ Qualify No Co-Pay One-Time Dose ✅ Free — High-Risk 60–74 $0 — If Criteria Met Adults 60–74 qualify free if they: reside in a long-term care home, Elder Care Lodge, or retirement home; are a hospital patient receiving Alternate Level of Care (ALC) or complex continuing care; or have moderately-to-severely immunocompromising glomerulonephritis. LTC Residents ALC Patients Specific Conditions 💳 Private Purchase — 60–74 Without Criteria ~$250 Out-of-Pocket Adults 60–74 who live in the community and do not meet high-risk criteria can purchase with a prescription. Cost approximately $250 at pharmacies. Some private insurers cover all or part. Check your drug plan before paying out-of-pocket. Ministry does not reimburse. Prescription Required Check Insurance Not at Pharmacy (Free) ⚠️ Not Currently Funded — Under 60 Private Only (50–59) Adults under 60 are not currently covered by Ontario’s program. NACI guidance acknowledges the vaccine may be considered for adults 50–74 as an individual decision with a healthcare provider, particularly for those with chronic cardiopulmonary disease or immunocompromising conditions. No Ontario Funding NACI: Consider if High-Risk ⚠️ Critical: The Free Vaccine Is Not Available Through Pharmacies Ontario’s publicly funded RSV vaccine supply is distributed to family doctors, nurse practitioners, public health immunization clinics, and long-term care or retirement home facilities. It is not available at pharmacies as a free service. If you walk into a pharmacy requesting the publicly funded vaccine, you will be asked to pay. To access the free vaccine, contact your family doctor or nurse practitioner, or book through your local public health unit’s immunization clinic. In Toronto, the Scarborough Centre for Healthy Communities and city immunization clinics offer this by appointment for eligible residents. Sources: ontario.ca/page/rsv-prevention-programs (eligibility and delivery rules, Dec 2025); toronto.ca/rsv-immunization (Toronto Public Health: “not available through pharmacies,” Dec 2025); eohu.ca/rsv-2025 (Eastern Ontario Health Unit, Oct 2025); wdgpublichealth.ca/clinics/rsv (~$250 cost, private insurance note); tbdhu.com/rsvvax (Thunder Bay DH, private purchase process) 🧬 Why RSV Is Serious for Older Adults: The Evidence RSV is widely underestimated as a threat to older adults. Many seniors — and even some healthcare providers — still think of it as a childhood illness. The published science tells a different story. 16% of Ontario adults hospitalized for RSV are admitted to ICU (CCDR Jan 2025) 5–9% in-hospital case fatality ratio for adults hospitalized with RSV in Canada $43,721 mean additional healthcare cost over 2 years per RSV hospitalization in Ontario 📊 What Canadian Research Shows About RSV in Older Adults RSV is comparable to influenza in disease burden for seniors. A comprehensive review published in the Canada Communicable Disease Report (January 2025) found that the burden of severe RSV outcomes is close to the influenza burden in older adults — yet RSV historically received far less public health attention. Hospitalization severity increases steeply with age. A study in the Journal of Infectious Diseases (November 2025, Oxford Academic) using Ontario hospitalization data from 2017–2019 found that adults aged 80 and older had the highest incidence of RSV-associated hospitalization of any age group. RSV causes serious cardiovascular complications after hospitalization. A 2025 study published in the Journal of the American Geriatrics Society, involving University Health Network in Toronto, found that RSV hospitalization was associated with more severe outcomes — including greater cardiovascular events — than influenza hospitalization in older adults. Rates of heart attack and stroke were significantly elevated in the weeks following RSV hospitalization. Long-term healthcare costs are significant. A retrospective population-based study using Ontario data found that adults hospitalized with RSV incurred a mean difference of $28,260 in attributable healthcare costs in the first 6 months, and $43,721 over two years, compared to matched non-hospitalized controls (Vaccine, 2023). RSV risk is not just about age — comorbidities matter for all ages. The 2025 Ontario hospitalization study found that the presence of underlying conditions (heart disease, COPD, immunocompromise, diabetes) was as important as age in predicting severe RSV outcomes, which is why the NACI guidance extends eligibility consideration to adults 50 and over who are at higher risk. 🧪 What the Vaccine Trials Show Arexvy (GSK): ~83% efficacy against lower respiratory tract disease caused by RSV in adults 60+; approximately 94% efficacy against severe RSV-associated illness (Health Canada/FDA analysis of Phase 3 trial data). Abrysvo (Pfizer): similarly high efficacy in preventing RSV lower respiratory tract disease. NACI notes all three approved vaccines show similar reductions in hospitalizations and medically attended RSV respiratory tract infections for adults 60 and older. mRESVIA (Moderna mRNA-1345): Approved by Health Canada in May 2025 for adults 60+. The first mRNA RSV vaccine for older adults. Not yet provincially funded in Ontario as of early 2026, but available for private purchase with a prescription. NACI guidance includes it in recommendations alongside Arexvy and Abrysvo. Duration of protection: Studies show multi-year protection from a single dose. The exact duration is still being studied — NACI states no booster is currently recommended, but the timing for a possible future repeat dose is unknown pending ongoing research. Safety profile: Vaccines are well-tolerated. Common side effects include injection site pain, fatigue, headache, muscle or joint pain, and mild nausea — typically lasting a few days. These are consistent with other adult vaccines. Sources: CCDR Jan 2025 51(1): Abrams et al. “Burden of disease of RSV in older adults” (PMC11709116; ICU 16%, CFR 5–9%, comparable influenza burden); J Infectious Diseases Nov 2025 232(5): Buchan et al. Ontario 2017–2019 hospitalization study (Oxford Academic, 80+ highest incidence, comorbidities); JAGAS 2025: Verschoor et al. UHN Toronto (PMC12460985; RSV more severe than influenza, cardiovascular outcomes); Vaccine 2023: Mac et al. ($28,260 / $43,721 attributable costs, Ontario); CCDR Aug 2025 51(8): NACI summary (Arexvy/Abrysvo/mRESVIA similar efficacy); Health Canada / FDA Arexvy approval (83% LRTD, 94% severe); Canada.ca CCDR 51(2/3) cost-effectiveness Feb–Mar 2025 (Arexvy cost-effective up to $139/dose) 💉 The RSV Vaccines Available in Ontario Arexvy® (RSVPreF3) GSK • Health Canada approved 2023 For adults 60 years and older Single intramuscular injection ~83% efficacy vs. RSV LRTD; ~94% vs. severe disease One of two products publicly funded by Ontario Available via family doctor or public health clinic Available privately at pharmacies with prescription Abrysvo® (RSVpreF) Pfizer • Health Canada approved 2023 For adults 60 years and older; also for pregnant people 32–36 weeks Single intramuscular injection Similar efficacy profile to Arexvy per NACI review One of two products publicly funded by Ontario Available via family doctor or public health clinic Available privately at pharmacies with prescription mRESVIA® (mRNA-1345) Moderna • Health Canada approved May 2025 • Not yet provincially funded in Ontario Canada’s first mRNA RSV vaccine for adults 60+ Same mRNA technology platform as COVID-19 vaccines Included in NACI recommendations alongside Arexvy and Abrysvo Not yet part of Ontario’s publicly funded program — available privately with prescription Check with your pharmacy for current availability and cost 💬 Does It Matter Which Vaccine You Get? NACI’s review found that Arexvy (GSK) and Abrysvo (Pfizer) show similar reductions in hospitalizations and medically attended RSV respiratory tract infections for adults 60 and older. Ontario publicly funds both products, and your family doctor or public health clinic will administer whichever product is available in their supply. You do not need to request a specific brand — both are effective. If you are purchasing privately at a pharmacy, ask which products they carry and confirm the price before proceeding. Sources: ontario.ca/rsv (Arexvy and Abrysvo publicly funded, Dec 2025); Health Canada (Arexvy approved Aug 2023; Abrysvo 2023; mRESVIA approved May 2025); NACI CCDR Aug 2025 (similar efficacy, three products); opa.org/pharmacists (product overview for pharmacists, Oct 2024) ❓ Frequently Asked Questions I am 72 and healthy with no conditions. Can I still get the vaccine for free? + Not through the publicly funded program, no. Ontario’s free RSV vaccine for adults aged 60 to 74 is restricted to those who meet specific high-risk criteria — primarily people living in long-term care, Elder Care Lodges, or retirement homes, patients receiving Alternate Level of Care in hospital, or those with specific immunocompromising conditions like moderately-to-severely immunocompromised glomerulonephritis. A healthy 72-year-old living independently in the community does not currently qualify for the free program. Your options are: wait until you turn 75 (when you qualify automatically), or purchase the vaccine privately for approximately $250 with a prescription from your family doctor. Some private insurance drug plans cover RSV vaccines — check your benefit booklet or call your insurer before paying out of pocket. NACI guidance does state that adults aged 50 to 74 may consider the vaccine as an individual decision in consultation with their healthcare provider, particularly if they have underlying health conditions that increase their personal risk. I had an RSV vaccine last season. Do I need another one? + No. If you already received a publicly funded RSV vaccine in a previous season, you do not need another dose this season. This is confirmed by the Ontario Ministry of Health, Ottawa Public Health, Toronto Public Health, and every local health unit that has published RSV guidance for the current season. The RSV vaccine is not like the flu shot — it does not need to be given every year. NACI does not currently recommend booster doses. Research is ongoing to determine exactly how long protection lasts following a single dose, but the current guidance is clear: one publicly funded dose per person, no repeat needed. If you are unsure whether you received the publicly funded vaccine or a private purchase, check with your family doctor who should have a record in your immunization file. If you received the vaccine privately at a pharmacy, that would also typically be recorded. What you should still get this fall: your annual flu shot and any updated COVID-19 vaccine dose for which you are eligible. These can all be given at the same appointment. Where exactly do I go to get the free RSV vaccine in Ontario? + Your family doctor or nurse practitioner is the primary access point for eligible seniors in Ontario. Call your family doctor’s office in early fall — ideally September — and let them know you are 75 or older and would like to book the RSV vaccine. Most primary care offices receive the provincially funded vaccine supply and administer it as part of routine fall immunization appointments. If you do not have a family doctor, or cannot get an appointment through your primary care provider, contact your local public health unit. Options include: Ottawa: Ottawa Public Health immunization clinics — book at OttawaPublicHealth.ca/RSV Toronto: Scarborough Centre for Healthy Communities and City of Toronto immunization clinics by appointment Thunder Bay: TBDHU clinic at 999 Balmoral Street — book online at TBDHU.com/vaxclinics Wellington-Dufferin-Guelph area: WDG Public Health immunization clinic — book at wdgpublichealth.ca or call 1-800-265-7293 All regions: Search “[your city or region] + public health + RSV vaccine” to find your local health unit’s booking page If you live in a long-term care home, Elder Care Lodge, or retirement home, the vaccine will be offered to you directly through your facility’s care team — you do not need to make any arrangements yourself. Can I get the RSV vaccine at the same time as my flu shot? + Yes — and Ontario health authorities specifically encourage it. The RSV vaccine can be co-administered on the same day as the influenza (flu) vaccine, the COVID-19 vaccine, and other routine adult vaccines. Co-administration does not reduce the effectiveness of any of the vaccines involved, and it significantly simplifies your fall immunization schedule. Getting all three vaccines — RSV, flu, and COVID-19 — at a single appointment means fewer trips to your doctor and fewer days when you might delay getting protected. The City of Ottawa, Ontario Ministry of Health, and local public health units all emphasize co-administration as a practical advantage for older adults, particularly those who find travel to medical appointments difficult. Practically speaking: when you call your family doctor to book your flu shot, mention that you would also like the RSV vaccine and your COVID-19 booster if eligible. Your doctor’s office can plan the appointment accordingly and ensure all three vaccines are on hand. What are the side effects of the RSV vaccine? + The RSV vaccines (Arexvy and Abrysvo) have well-documented safety profiles from large clinical trials and are considered well-tolerated by older adults. Common side effects include: Pain, redness, or swelling at the injection site — the most common effect, usually mild and resolving within 1 to 3 days Fatigue (feeling tired) — typically lasting 1 to 2 days Headache Muscle or joint pain Mild nausea or diarrhea These side effects are consistent with other adult vaccines and typically mild. They are a normal sign that your immune system is responding to the vaccine. A rare but monitored concern: Early post-market safety surveillance in the United States raised a signal around a possible slight increase in Guillain-Barré Syndrome (GBS) — a rare neurological disorder — following RSV vaccination. Health Canada, NACI, and the US FDA continue to monitor this signal. Current guidance from all authorities is that the benefits of RSV vaccination clearly outweigh this potential risk in older adults, particularly those at higher risk of severe RSV disease. If you have a personal or family history of GBS, discuss this with your healthcare provider before receiving the vaccine. If you experience any severe or unusual symptoms after receiving the vaccine — such as difficulty breathing, chest pain, or neurological symptoms — seek medical attention promptly and report the event to your healthcare provider so it can be documented. My private insurance covers some vaccines. Will it cover the RSV vaccine if I have to pay? + Possibly — but you need to check your specific plan before paying out of pocket. Many employer-sponsored group drug plans, retiree benefit plans, and some individual private health insurance policies include coverage for vaccines, including newer ones like RSV. However, coverage is far from universal and depends entirely on your specific plan’s formulary and benefit structure. Steps to check your coverage: Call your insurer directly and ask: “Does my drug or health benefit plan cover RSV vaccines for adults, such as Arexvy or Abrysvo? And does it cover the administration fee if I receive it at a pharmacy or doctor’s office?” Check your benefit booklet — look for the section on vaccines, immunizations, or preventive health benefits. Ontario Drug Benefit (ODB): The provincial ODB formulary does not currently list RSV vaccines for community-dwelling seniors outside the public program. If you receive ODB benefits, check directly with your pharmacist or the Ministry of Health. If your insurer covers it: Get the prescription from your doctor, have the vaccine administered at a pharmacy or doctor’s office, pay upfront if required, then submit the receipt to your insurer for reimbursement according to your plan’s process. The Ontario Ministry of Health explicitly states it does not reimburse individuals who purchase vaccines privately, regardless of eligibility status. The only path to a free RSV vaccine for eligible seniors is through the publicly funded program via their family doctor or a public health clinic. How is RSV different from a cold or the flu? Why do I need a separate vaccine? + RSV (Respiratory Syncytial Virus) is a distinct respiratory virus from influenza and rhinoviruses (the common cold). It is caused by a different virus and the vaccines for each disease only protect against the specific virus they target — the flu vaccine does not protect against RSV, and the RSV vaccine does not protect against influenza. Why RSV can be more dangerous in seniors than it appears: RSV initially presents with cold-like symptoms: runny nose, cough, sneezing, mild fever. This is deceptive — for most younger adults and healthy people, these mild symptoms are the full extent of the illness. However, in adults aged 65 and older — especially those with heart disease, COPD, diabetes, or immune system conditions — the virus can spread to the lower respiratory tract, causing bronchitis or pneumonia that requires hospitalization. Unlike influenza, which most Ontarians recognize and respect as a serious illness, RSV is underrecognized. Research shows it is tested for far less frequently than flu, meaning many RSV infections in older adults are misdiagnosed or attributed to other causes. A 2025 study at University Health Network Toronto found that older adults hospitalized for RSV had significantly higher cardiovascular event rates in the weeks after discharge — suggesting RSV does damage beyond the lungs. Think of RSV vaccination as adding a third protective layer to your fall respiratory defense: flu vaccine + COVID-19 vaccine + RSV vaccine. Each covers a different, serious respiratory threat that Ontario winters bring. I have COPD, heart disease, or diabetes. Does that affect my eligibility or urgency? + Having COPD, heart disease, or diabetes increases your personal risk from RSV significantly, and this matters for both eligibility and urgency. For eligibility: These conditions alone do not automatically qualify you for the free vaccine if you are 60 to 74 and living in the community. The current free criteria for 60–74-year-olds focus on care setting (LTC, retirement home, ALC) rather than medical conditions in most cases. The exception is the specific condition of moderately-to-severely immunocompromising glomerulonephritis, which is narrow. For urgency: The research is clear that comorbidities like COPD, heart failure, and diabetes substantially increase the risk of severe RSV disease. A CCDR 2025 burden study confirmed that incidence of severe RSV disease increases with the presence of underlying conditions across all age groups. NACI guidance specifically acknowledges that adults 50 to 74 with chronic cardiopulmonary disease or immunocompromising conditions should consider the vaccine as an individual decision with their healthcare provider — even though Ontario does not fund it for this group. Practical advice: If you are 60 to 74 with COPD, heart disease, or diabetes and living in the community, have an honest conversation with your family doctor about your personal RSV risk and whether the ~$250 private purchase cost makes sense for your health profile. Your doctor can advise on your individual risk level and whether your private insurance might cover the cost. 🎯 Check Your RSV Vaccine Eligibility 💉 Answer 3 Questions — See Your Eligibility and Next Step What is your age? Ontario’s eligibility is primarily age-based, with added criteria for the 60–74 group. Under 50 years old 50 to 59 years old 60 to 74 years old 75 years old or older Where do you currently live or receive care? Your living situation affects your eligibility for the free program if you are 60 to 74. At home, independently in the community In a long-term care home or Elder Care Lodge In a retirement home or assisted living In hospital receiving Alternate Level of Care (ALC) Have you already received an RSV vaccine funded by Ontario? If you received a free RSV vaccine in a prior season through the provincial program, you do not need another dose. No, I have never received an RSV vaccine I paid for one privately — I was not funded Yes, I received one through the public / free program I am not sure if I have had one or not 💉 Check My Eligibility 📍 Find RSV Vaccine Clinics Near You in Ontario Use the buttons below to locate public health vaccine clinics, family health teams, and pharmacies near you in Ontario. 🏥 Public Health Vaccine Clinic Near Me 👩⚕️ Family Doctor or Health Team Near Me 💊 Pharmacy RSV Vaccine Near Me (Private Purchase) 💉 Book Flu + COVID + RSV Together Near Me Finding clinics near you… ✅ Your RSV Vaccine Action Plan If you are 75 or older and have never had a provincially funded RSV vaccine: Call your family doctor in early fall (September) and book the RSV vaccine alongside your flu shot. If you do not have a doctor, contact your local public health unit’s immunization clinic. Bring your OHIP card. The vaccine is free. If you are 60 to 74 and live in LTC, a retirement home, or ALC: Your facility will offer the vaccine to you — ask your care team if you have not been contacted by October. If you are 60 to 74 and live independently: Call your insurer first to check drug plan coverage, then discuss with your family doctor. The out-of-pocket cost is approximately $250 with a prescription administered at a pharmacy. NACI supports the vaccine as an individual decision at this age, particularly if you have heart disease, COPD, or other conditions. If you are under 60 with high-risk conditions: Speak to your family doctor about your personal risk. NACI guidance acknowledges consideration for adults 50+ with chronic conditions, though Ontario does not currently fund this group. Whatever your situation: Get your flu vaccine and any COVID-19 booster you are eligible for this fall. These can be given at the same appointment as the RSV vaccine. 📞 Key Contacts Ontario Ministry of Health RSV page: ontario.ca/page/respiratory-syncytial-virus-rsv-prevention-programs Ottawa Public Health RSV booking: OttawaPublicHealth.ca/RSV Wellington-Dufferin-Guelph Public Health: 1-800-265-7293 ext. 7006 or wdgpublichealth.ca Thunder Bay DH vaccine clinic booking: TBDHU.com/vaxclinics Toronto Public Health immunization: toronto.ca/rsv-immunization Find your local public health unit (all Ontario): Search “[your city] + public health unit + RSV vaccine 2025” NACI official guidance: canada.ca — search “NACI RSV statement older adults” 💬 A Word from BudgetSeniors.com The RSV vaccine program expansion in Ontario for adults 75 and older is a meaningful and well-evidenced public health decision. The science is solid: RSV causes serious illness, hospitalization, and cardiovascular complications in older adults at rates comparable to influenza, yet it has long been underrecognized. The good news is that for the majority of Ontario seniors aged 75 and older, protection is now completely free and available through your family doctor. Getting the RSV vaccine this fall alongside your flu shot is one of the most effective preventive health decisions you can make — at no cost whatsoever if you qualify. Sources: ontario.ca/page/respiratory-syncytial-virus-rsv-prevention-programs (Ministry of Health, Dec 2025); NACI CCDR 51(8) Aug 2025 (Killikelly et al., summary of RSV statement); CCDR 51(1) Jan 2025 (Abrams et al., burden of disease; ICU 16%, CFR 5–9%); CCDR 51(2/3) Feb–Mar 2025 (cost-effectiveness Canada.ca); JAGAS 2025 (Verschoor et al., UHN Toronto; PMC12460985); J Infect Dis 232(5) Nov 2025 (Buchan et al., Oxford, 80+ highest incidence); Vaccine 2023 (Mac et al., $28,260/$43,721 attributable costs); PubMed 39004648 (hospitalization incidence Ontario); CBC News Aug 27, 2025; Global News Aug 27, 2025; Lung Health Foundation Nov 2025; Ottawa Public Health newsroom; EOHU Oct 2025; Toronto Public Health Dec 2025; WDG Public Health (~$250 cost); Thunder Bay DH; OMA RSV program note; Ontario Pharmacists Association (OPA) RSV pharmacist guide Ⓡ BudgetSeniors.com — Helping Seniors in Canada Make Smart, Informed Health & Financial Decisions Recommended Reads 12 Free Rabies Clinic Near Me A24 Membership (AAA24) 12 Best Ethanol Free Gas Near Me Medicare Part D $2000 Cap 20 Free and Low-Cost Veterinary Care for Low Income Near Me AAA Membership Hotel Discounts Free Lawyers for Low-Income Families Allstate Insurance Blog